Genetic variants in immune mediators as potential molecular biomarkers for oral cancer evaluation: Insights from a systematic revaluation by computational analyses and Bayesian approaches
Oral Oncology Reports · 2025-03 · 13 · 100729
DOI: 10.1016/j.oor.2025.100729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Oncology Reports, 2025-03. Verfasst von Juliana Campos Botelho und 13 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Oral cancer is a complex disease in which genetic variations in immune mediator play a relevant role in its pathophysiology. This study aimed at assessing the level of false-positive rates on meta-analytic data on genetic variations in immune mediator genes related with oral cancer risk. A systematic search was performed for meta-analyses in this field that were published before September 22, 2024. The calculations for the False-Positive Rate Probability (FPRP) and the Bayesian False Discovery Probability (BFDP) were performed to assess the noteworthiness with a statistical power of 1.2 and 1.5 of Odds Ratio (OR) at a prior probability of 10 −3 and 10 −6 . A methodological evaluation by the Venice criteria was performed and in silico networks were designed. Ten meta-analyses on the TNFA /rs361625/rs1800629, VEGF /rs3025039, IL4 /rs2070874, IL6 /rs1800795, IL8 /rs4073 and IL10 /rs1800896 genes/polymorphisms and oral cancer have been included. 88 significant OR association values from the meta-analyses included allowed the performance of 336 calculations for FPRP and 176 for BFDP. We found 35 noteworthy values (10.42 %) for FPRP and 59 noteworthy values (33.52 %) for BFDP that demonstrated the variants in VEGF and IL10 with noteworthiness association with oral cancer. The gene-gene and protein-protein networks evidenced the role of VEGF, TNFA, IL4, IL6, IL8 and IL10 genes in the physiopathology of the disease. The Bayesian calculations and the in-silico analyses indicated the rs3025039 and rs1800896 polymorphisms in the VEGF and IL10 genes, respectively, as noteworthy molecular biomarkers for oral cancer risk evaluation. • The VEGF and IL10 genetic variants were noteworthy by Bayesian calculations. • The rs3025039 and rs1800896 polymorphisms are likely biomarkers for oral cancer. • The VEGF, TNFA, IL4, IL6, IL8 and IL10 are relevant gene mediators in oral cancer.
Zitieren
APA
Botelho, J. C., Brasileiro, S. A., Monteiro, A. V. O., Leal, A. L. A. B., Santos, N. N. D. C. D., Alves, G. R., Koga, R. S., Silva, H. A. D., Monteiro, J. R. S., Ferreira, D. V. G., Pereira, A. L., Oliveira, A. C. A. D., Duarte, M. S. S. L., & Silva, F. R. P. D. (2025). Genetic variants in immune mediators as potential molecular biomarkers for oral cancer evaluation: Insights from a systematic revaluation by computational analyses and Bayesian approaches. Oral Oncology Reports, 13, 100729. https://doi.org/10.1016/j.oor.2025.100729
Vancouver
Botelho JC, Brasileiro SA, Monteiro AVO, Leal ALAB, Santos NNDCD, Alves GR, et al. Genetic variants in immune mediators as potential molecular biomarkers for oral cancer evaluation: Insights from a systematic revaluation by computational analyses and Bayesian approaches. Oral Oncology Reports. 2025;13:100729. doi:10.1016/j.oor.2025.100729
BibTeX
@article{Botelho2025,
author = {Botelho, Juliana Campos and Brasileiro, Samuel Arcebispo and Monteiro, André Victor Oliveira and Leal, Alessandro Luiz Araújo Bentes and Santos, Naum Neves da Costa dos and Alves, Gabrielly Ribeiro and Koga, Reyce Santos and Silva, Haline Alves da and Monteiro, José Rogério Souza and Ferreira, Denis Vieira Gomes and Pereira, Adenilson Leão and Oliveira, Ana Carolina Alves de and Duarte, Márcia Socorro Silva Lima and Silva, Felipe Rodolfo Pereira da},
title = {Genetic variants in immune mediators as potential molecular biomarkers for oral cancer evaluation: Insights from a systematic revaluation by computational analyses and Bayesian approaches},
journal = {Oral Oncology Reports},
year = {2025},
volume = {13},
pages = {100729},
doi = {10.1016/j.oor.2025.100729}
}
EUVIMED